The Pharmacy Times® Reproductive Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to reproductive health and medicine.
Long-Acting Injectable Form of Cabotegravir Safe for HIV Prevention in Pregnant Cisgender Women
July 29th 2024An extension of a long-acting cabotegravir study shows safety prior to and during pregnancy in cisgender women, with full results being presented at the 2024 International AIDS Conference.
Read More
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
July 23rd 2024Following President Joe Biden’s decision to step down from re-election, VP Kamala Harris has stepped into the Democratic nominee position after support and endorsements from notable delegates and the president himself.
Read More
Study Finds 1 in 10 Pregnant Individuals Who Test Positive For COVID-19 Will Develop Long COVID
July 17th 2024The investigators note that the high prevalence of long COVID, including in pregnant individuals, emphasizes a need for health care professionals and patients to closely monitor symptoms.
Read More
Babies of Mothers Prescribed GLP-1s Prior to Pregnancy May Have Increased Risk of NICU Stays
July 1st 2024Additionally, birth weight was higher in babies born to mothers who were prescribed glucagon-like peptide-1 (GLP-1) medications either 90 days prior to pregnancy or during the first trimester.
Read More